Literature DB >> 29930124

Aberrant choice behavior in alcoholism.

Rainer Spanagel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29930124     DOI： 10.1126/science.aau0668

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

Review 1.  [A selective review of recent research results in biological psychiatry].

Authors:  A Meyer-Lindenberg
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

2.  Reduced motor cortex GABABR function following chronic alcohol exposure.

Authors:  Shi-Yu Peng; Zhe Shi; Dong-Sheng Zhou; Xin-Yue Wang; Xing-Xing Li; Xiao-Li Liu; Wei-Di Wang; Guan-Ning Lin; Bing-Xing Pan; Valerie Voon; Anthony A Grace; Markus Heilig; Ma-Li Wong; Ti-Fei Yuan
Journal:  Mol Psychiatry       Date:  2021-01-11       Impact factor: 15.992

Review 3.  Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.

Authors:  Paola Maccioni; Giancarlo Colombo
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 4.  Suppressing Effect of Baclofen on Multiple Alcohol-Related Behaviors in Laboratory Animals.

Authors:  Giancarlo Colombo; Gian Luigi Gessa
Journal:  Front Psychiatry       Date:  2018-09-28       Impact factor: 4.157

5.  Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?

Authors:  D Longrois; F Petitjeans; O Simonet; M de Kock; M Belliveau; C Pichot; Th Lieutaud; M Ghignone; L Quintin
Journal:  Rom J Anaesth Intensive Care       Date:  2021-01-04

Review 6.  A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder.

Authors:  Renaud de Beaurepaire
Journal:  Front Psychiatry       Date:  2018-10-17       Impact factor: 4.157

7.  Baclofen decreases compulsive alcohol drinking in rats characterized by reduced levels of GAT-3 in the central amygdala.

Authors:  Lucia Marti-Prats; Aude Belin-Rauscent; Maxime Fouyssac; Mickaël Puaud; Paul J Cocker; Barry J Everitt; David Belin
Journal:  Addict Biol       Date:  2021-02-01       Impact factor: 4.280
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.